Abbott, Oasmia Join To Market New Cancer Medicine For Dogs – Update – RTT News


Abbott, Oasmia Join To Market New Cancer Medicine For Dogs - Update
RTT News
The medicine is a new formulation of the active ingredient paclitaxel, which is used in the treatment of cancer in humans since 1993. by RTT Staff Writer.

and more »

If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Comments

No comments yet.

Sorry, the comment form is closed at this time.